More: Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed
More: Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed
Continued here: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Read more from the original source: Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
Read this article: Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
View post: BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patients with Transthyretin Amyloid Cardiomyopathy...
Read more here: Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
See the rest here: Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024
Read the original post: Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
Link: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results
Recent Comments